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Abstract
Thyroid nodules (TN) are a common clinical problem. Fine needle aspiration (FNA) of the thyroid
now is practiced worldwide and proves to be the most economical and reliable diagnostic
procedure to identify TNs that need surgical excision and TNs that can be managed conservatively.
The key for the success of thyroid FNA consists of an adequate or representative cell sample and
the expertise in thyroid cytology. The FNA cytologic manifestations of TNs may be classified into
seven working cytodiagnostic groups consisting of a few heterogenous lesions each to facilitate the
differential diagnosis. Recent application of diagnostic molecular techniques to aspirated thyroid
cells proved to be useful in separating benign from malignant TNs in several cases of indeterminate
lesions.
Fine-needle aspiration (FNA) for cytologic evaluation of
thyroid cancer was originally used by Martin and Ellis at
New York Memorial Hospital for Cancer and Allied Dis-
eases in 1930 [1]. However, this diagnostic procedure was
subsequently found to have a limited value, and it was
then discontinued at the above-mentioned institution
[2,3]. The thyroid FNA was not further developed and did
not gain acceptance in the United States for nearly 50
years until the early 1980s when its diagnostic value was
firmly demonstrated by Scandinavian investigators [4-8].
The 1974 report by Crockford and Bain [9] and the 1979
paper of Miller and Hamburger [10] were apparently the
first North American publications attesting to the value of
thyroid FNA. This method of clinical investigation now is
practiced worldwide and has become the cornerstone in
the management of thyroid nodules (TN) [11-25].ing of
thyroid cancer cells along the needle tract is also an
exceedingly rare complication with FNA [13].
Indication and Goal of Thyroid FNA
Thyroid nodular lesions are a common clinical problem.
In the United States, 4 to 7% of the adult population have
a palpable TN [13]. The incidence of thyroid cancer in a
clinically solitary TN or in a multinodular goiter is equal
and about 5% in non-endemic areas [26]. TNs constitute
the main indication for FNA, and the goal of this diagnos-
tic procedure is to detect thyroid neoplasms for surgical
resection and to identify non-neoplastic lesions that may
be managed conservatively [23]. This method of clinical
investigation has reduced the number of diagnostic thy-
roid surgeries for TNs by 60–85%, and the difference in
rates of thyroid surgery reflect the cytodiagnostic accuracy
rates among different medical centers [24].
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Contraindications and Complications of Thyroid 
FNA
The main contraindication to thyroid FNA is bleeding dia-
thesis, as the formation of a large hematoma at the biopsy
site may cause compression of the trachea and respiratory
distress [13,23]. Therefore, a bleeding time, PT and PTT
should be ordered to screen this condition in all patients
prior to thyroid FNA. This diagnostic procedure, if prop-
erly performed, is almost free of complications. Subcuta-
neous hematoma at the biopsy site, accidental puncture of
the trachea and local infection are rare complications
[13]. Hematoma may be prevented by local pressure of
the overlying skin at the biopsy site [13]. Tracheal injury
is manifested by minimal and transient hemoptysis. Seed-
ing of thyroid cancer cells along the needle tract is also an
exceedingly rare complication with FNA [13].
Procuration and Preparation of Cell Samples
1. Procurement of cell samples
Obtaining an adequate or satisfactory cell sample for cyto-
logic evaluation is not simple, and interpreting thyroid
cytology is challenging and requires expertise [13,23]. To
perform thyroid FNA, the TN is identified by palpation,
and a 22- to 25-gauge and 4.5-cm-long needle is com-
monly used to procure cell samples from at least three dif-
ferent areas of any TN. Usually, only dermal anesthesia is
required. Depending on personal preferences FNA of a TN
may be performed either with or without a syringe [13].
However, for cystic thyroid lesions, the cyst contents
should be evacuated first by FNA with a syringe. The gland
is then carefully examined by palpation. If a residual nod-
ule is found, it should be aspirated. If the TN is difficult to
identify by palpation the patient should be referred to a
radiologist for FNA under ultrasonographic guidance
[13,22-24]. Since the thyroid is rich in capillary blood ves-
sels the needle aspirate usually contains a large amount of
peripheral blood that may be reduced by limiting the
biopsy procedure to about five seconds or by using the
FNA technique without aspiration [13].
2. Preparation of cell samples
For cytological evaluation, smears should be appropri-
ately prepared and stained. Depending on the amount
and nature of the thyroid needle aspirates one of the fol-
lowing preparation techniques is used: (a). A small drop
of thyroid aspirate is put near the frosted end of a glass
slide and is quickly and gently smeared by a cover slip.
(b). A small drop of thyroid aspirate is put on a glass slide
and gently crushed with a second slide that is then sepa-
rated vertically from the first one. (c). A small or medium-
sized drop of thyroid aspirate is put near the frosted end
of a slide that is placed on a table. A second slide is used
to spread the aspirated material in the same manner used
to prepare a peripheral blood smear. (d) Cytospin smears
should be prepared from the liquid contents of all cystic
thyroid lesions. (e). Excess of aspirated material should be
used for preparation of a cell block that may show diag-
nostic tissue fragments on sectioning. It is important that
a small drop of aspirated material is used for smear prep-
aration, as if a large drop of aspirate material is used, an
unevenly thick smear may be obtained, and at the end of
the slide a thick and bloody cell film may be formed. This
will obscure the cellular details of underlying thyroid cells
and tissue fragments, making their evaluation extremely
difficult, if not impossible.
3. Routine staining methods
Depending on personal preference, either air-dried and
Romanowsky-stained smears or ethanol-fixed and Papan-
icolaou-stained smears are prepared. For Papanicolaou
staining, the smears must be fixed quickly before drying
with 95% ethanol or with a commercial spray fixative. A
delay in fixation will result in air-dried artefactual changes
with loss of cellular details. Air-dried smears for staining
with one of the Romanowsky modified methods (Wright
stain, May-Grunwald-Giemsa or Diff-Quik method) now
are widely used, as air-drying artifactual changes can be
avoided. However, nuclear details in Romanowsky-
stained smears are not as well-visualized as in wet-fixed
and Papanicolaou-stained smears. A parallel use of air-
dried and wet-fixed smears is usually recommended, as
these two staining methods are complementary
[13,22,23]. Fixation of aspiration smears in Carnoy solu-
tion for 3–5 minutes may be used to lyse red blood cells
prior to staining with the Papanicolaou method.
Specimen Adequacy
Obtaining an adequate cell sample is a prerequisite to the
success of thyroid cytology. Therefore, immediate micro-
scopic assessment of the needle aspirate by a pathologist
or a cytotechnologist is desirable. If the first sample is
judged inadequate for cytological evaluation, the TN can
be re-aspirated immediately. If a rapid evaluation is not
available, multiple FNAs of different areas of the TN
should be performed.
The range of inadequate or unsatisfactory specimens
reported in the literature ranges from 2–21% (means
17%) [15]. Currently, criteria for specimen adequacy vary
from institution to institution. Some investigators require
that an adequate sample should contains five to six groups
of well-preserved and well-visualized follicular cells with
each group containing 10 or more cells [12]. One group
requires multiple punctures of the TN to be evaluated,
with at least six properly prepared smears and a minimum
of 8–10 tissue fragments of well-preserved follicular epi-
thelium on each of two slides [25]. Another group
requires 10 clusters of follicular cells with at least 20 cells
in each cluster [13]. The Papanicolaou Society of Cytopa-
thology Task Forces on Standard of Practice does notCytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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specify any numbers and groups of thyroid follicular epi-
thelial cells for specimen adequacy [23]. Two practical
exceptions to these adequacy criteria are applied: (a) a
benign colloid nodule may be suggested if a large amount
of thick colloid material is present, regardless of the
number of follicular epithelial cell clusters [23]; or, (b) if
a cell sample contains one or two small clusters of malig-
nant or highly atypical cells, it should be reported as
malignant or suspicious for malignancy and not as unsat-
isfactory or inadequate for cytodiagnosis [23]. Thyroid
FNA under ultrasonographic guidance achieved higher
rates of adequate cell samples, in the range of 79–99.3%
(mean, 91%) [21,27-36]. Ultrasound-guided thyroid FNA
proved to be useful in sampling TNs smaller than 2 cm in
greatest dimension, complex or solid-cystic TNs [27-36]
and abnormal thyroid beds [35,36].
Cytodiagnosis and Its Limitations
The cytodiagnosis of TNs by FNA is complex for the fol-
lowing reasons [26]:
a. overlap of cytological patterns between neoplastic and
non-neoplastic lesions.
b. overlap of cytological features between various
neoplasms.
c. coexistence of non-neoplastic and neoplastic processes
and multiple malignancies in the same gland.
For a practical diagnostic approach, the cytological find-
ings of thyroid lesions may be divided into seven main
groups, as recommended by the Papanicolaou Task Force
on Standard of Practice [23]. These groups are heteroge-
nous and consist of both neoplastic and non-neoplastic
lesions that may show either similar or specific cytological
manifestations [23]. A non-diagnostic group is added as
some TNs yield inadequate or non-specific cytological
findings. The above-mentioned groups with their com-
monly encountered thyroid lesions are tabulated in Table
1.
Table 1: Cytodiagnostic Groups with Commonly Encountered Thyroid Nodular Lesions*.
1. Benign colloid nodule - Solitary colloid nodule
- Prominent nodule in MNG
- Macrofollicular adenoma
2. Cellular microfollicular lesion - Microfollicular adenoma
- Low-grade follicular carcinoma
- Hyperplastic microfollicular lesions in HT or MNG
3. Hurthle cell lesion - Hurthle cell adenoma
- Hurthle cell carcinoma
- Hyperplastic Hurthle cell nodule in HT or MNG
4. Primary malignant tumor - Papillary carcinoma





5. Cystic lesions - Benign colloid nodule
- Papillary carcinoma
- Other thyroid neoplasms
6. Thyroiditis - Acute thyroiditis
- Hashimoto thyroiditis
- Subacute thyroiditis
7. Other lesions - Graves disease
- Metastatic cancer
8. Non-diagnostic category -
* HT, Hashimoto thyroiditis; MNG, multinodular colloid goiterCytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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1. Benign Colloid Nodule
This group includes solitary benign colloid nodules and
prominent benign colloid nodules in a multinodular colloid
goiter. These lesions arecharacterized by abundant, thick
colloid material with cracking or bubble pattern (Figs. 1
and 2) and sheets of benign follicular epithelial cells in
honeycomb arrangement (Fig. 3). Clusters of slightly
hyperplastic Hurthle cells may be present [12,22,23,25].
The cytological differential diagnosis between a benign
colloid nodule and a macrofollicular adenoma of the thy-
roid is extremely difficult if not impossible, as the two
lesions usually show abundant, thick colloid and similar
follicular cells [22,23].
2. Cellular Microfollicular Lesion
This group includes hyperplastic microfollicular nodules in a
multinodular colloid goiter or Hashimoto thyroiditis, a
microfollicular adenoma, and a well-differentiated follicular
carcinoma. These lesions are the most challenging ones to
diagnose cytologically [22-25]. They are commonly
reported as a microfollicular lesion or tumor with a rec-
ommendation for surgical excision [13,22-24]. FNA from
a microfollicular lesion usually reveals abundant follicu-
lar cells in clusters, acini and small monolayered sheets
(Figs 4 and 5). The individual cells show scanty, ill-
defined cytoplasm and oval nuclei with regular nuclear
contours and inconspicuous or prominent nucleoli.
Cellular microfollicular lesions of the thyroid fall into the
diagnostic category of indeterminate or suspicious lesions
[14,15,22], and in one large series 14% of microfollicular
lesions were malignant [12].
3. Hurthle Cell Lesion
Diagnosis of Hurthle cell lesions is a challenge in thyroid
cytology. A hyperplastic Hurthle cell nodule in a Hashimoto
thyroiditis or in a multinodular colloid goiter and a
Hurthle cell neoplasm display similar cytologic findings
[22-25,37,38]. The presence of numerous lymphocytes or
a large amount of thick colloid material in the needle aspi-
rate may indicate a hyperplastic Hurthle cell nodule in
Hashimoto disease or a multinodular colloid goiter,
respectively [38]. Hurthle cell adenoma and carcinoma
usually show similar cytologic findings that are
Thick, deep blue colloid material with cracking pattern in  FNA of a benign colloid nodule (Diff-Quik stain, × 250) Figure 1
Thick, deep blue colloid material with cracking pattern in 
FNA of a benign colloid nodule (Diff-Quik stain, × 250).
Thick, deep blue colloid material with bubble pattern in FNA  of a benign colloid nodule (Diff-Quik stain, × 250) view) Figure 2
Thick, deep blue colloid material with bubble pattern in FNA 
of a benign colloid nodule (Diff-Quik stain, × 250) view).
A monolayered sheet of benign follicular epithelial cells with  honeycomb pattern in FNA of a benign colloid nodule (Diff- Quik stain, × 400) Figure 3
A monolayered sheet of benign follicular epithelial cells with 
honeycomb pattern in FNA of a benign colloid nodule (Diff-
Quik stain, × 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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characterized by sheets and clusters of polygonal epithe-
lial cells with abundant, granular, eosinophilic or
basophilic cytoplasm, oval nuclei with regular nuclear
contours and conspicuous or inconspicuous nucleoli [22-
25] (Figs. 6 and 7). The presence of syncytial clusters of
Hurthle cells with or without prominent nuclei [25] and
abundant naked tumor cell nuclei has been reported to be
a feature of Hurthle cell carcinoma [38].
When a Hurthle cell lesion is detected by FNA, surgical
excision is usually indicated for further histologic study
[38]. Thyroid Hurthle cell lesions fall into the cytodiag-
nostic category of indeterminate lesions or suspected
malignant lesions [14,15,22], and 13% of Hurthle cell
lesions were malignant in one large series [12].
4. Primary Malignant Lesions
This group includes papillary, high-grade follicular, insular,
medullary and anaplastic carcinomas, and lymphoma. These
lesions commonly show distinctive cytologic features that
permit a correct identification in the majority of cases
[13,24,25]. An insular carcinoma, or poorly differentiated
Cellular microfollicular lesion showing in FNA cells with  round nuclei arranged in acini and small monolayered sheet  (Papanicolaou stain, 4 × 160 and 5 × 400) Figure 4
Cellular microfollicular lesion showing in FNA cells with 
round nuclei arranged in acini and small monolayered sheet 
(Papanicolaou stain, 4 × 160 and 5 × 400).
Cellular microfollicular lesion showing in FNA cells with  round nuclei arranged in acini (Papanicolaou stain, 4 × 160  and 5 × 400) Figure 5
Cellular microfollicular lesion showing in FNA cells with 
round nuclei arranged in acini (Papanicolaou stain, 4 × 160 
and 5 × 400).
Hurthle cells with abundant, granular cytoplasm and round,  central or eccentrically located nuclei in FNA of a Hurthle  cell lesion (Papanicolaou stain, × 400) Figure 6
Hurthle cells with abundant, granular cytoplasm and round, 
central or eccentrically located nuclei in FNA of a Hurthle 
cell lesion (Papanicolaou stain, × 400).
Hurthle cells in loose, monolayered sheet and singly in FNA  of a Hurthle cell lesion (Diff-Quik stain, × 400) Figure 7
Hurthle cells in loose, monolayered sheet and singly in FNA 
of a Hurthle cell lesion (Diff-Quik stain, × 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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carcinoma yields small cells in clusters, similar to those of
a high-grade microfollicular carcinoma [39].
4a. Papillary carcinoma (PC). The conventional PC is char-
acterized in FNA by the presence of thick or thin papillary
tissue fragments with fibrovascular cores, sheets of tumor
cells showing focal nuclear crowding and overlapping,
irregular nuclear contours, intranuclear cytoplasmic inclu-
sions (INCI) and nuclear grooves (NG). Psammoma bod-
ies and metaplastic squamous cells may also be present
[13,22,24,25] (Figs. 8, 9, 10, 11, 12, 13). These nuclear
changes are recognized with less difficulty in
Papanicolaou-stained cell samples, but they may be diffi-
cult to identify in cell samples stained with the
Romanowsky staining method [13,22,23]. However, a
presence of minute true papillary tissue fragments with
fibrous vascular cores even without the identifiable above-
mentioned nuclear changes is indicative of a PC. These
papillary tissue fragments should be differentiated from
thick and large follicular epithelial cell clusters with
vascular transgression that may be found in FNA from
different types of non-papillary epithelial neoplasms of
the gland [40].
- Micro- and  macrofollicular PCs constitute a diagnostic
challenge. A microfollicular PC may show in FNA follicu-
lar cells forming acini similar to those seen in the afore-
mentioned cellular microfollicular lesions, and a
macrofollicular PC may be easily mistaken for a macrofol-
licular adenoma or a benign colloid nodule cytologically,
as nuclear changes characteristic for a thyroid PC may not
be seen [41-43] (Fig. 14).
- Hyalinizing trabecular adenoma is indistinguishable from
a PC cytologically, as these two lesions yield cells with
similar nuclear features [44]. Recent molecular studies
have suggested that this tumor is actually an encapsulated
trabecular variant of thyroid PC [45].
- Other PC carcinoma subtypes. Tall-cell PC is characterized
by the presence of tall tumor cells with well-defined, gran-
ular cytoplasm and nuclei with NGs and single or
Thick branching papillary tissue fragment with fibrovascular  core in FNA of a conventional papillary carcinoma (Papanico- laou stain, × 100) Figure 8
Thick branching papillary tissue fragment with fibrovascular 
core in FNA of a conventional papillary carcinoma (Papanico-
laou stain, × 100).
Thin branching papillary tissue fragment with fibrovascular  core in FNA of a conventional papillary carcinoma (Papanico- laou stain, × 100) Figure 9
Thin branching papillary tissue fragment with fibrovascular 
core in FNA of a conventional papillary carcinoma (Papanico-
laou stain, × 100).
A sheet of tumor cells showing focal nuclear crowding with  several cells displaying nuclear grooves in FNA of a conven- tional papillary carcinoma (Papanicolaou stain, × 400) Figure 10
A sheet of tumor cells showing focal nuclear crowding with 
several cells displaying nuclear grooves in FNA of a conven-
tional papillary carcinoma (Papanicolaou stain, × 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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multiple INCIs, making at least 30% of the aspirated cells
[46-51] (Fig. 15). Columnar-cell variant shows no classic
cytologic features of thyroid PC, but presence of clusters of
columnar cells with palisading nuclei and the absence of
classic nuclear changes of thyroid PC are cellular features
of this neoplasm [52]. Diffuse sclerosing variant can be con-
fidently suggested when abundant squamous cells
admixed with lymphocytes, follicular epithelial cells with
nuclear features of papillary carcinoma and a few psam-
moma bodies are noted [53,54] (Fig. 16).
4b. A high-grade follicular carcinoma and insular carcinoma
are characterized by sheets and acinar clusters of pleomor-
phic epithelial cells with prominent nucleoli [22,24,25].
4c. A medullary carcinoma shows in FNA a mixture of single
and clustered polygonal cells and spindle tumor cells that
may display INCIs [22,24,25] (Figs. 17 and 18). The
tumor cells cytoplasm may show intracytoplasmic pink
azurophil granules that are well-visualized by MGG or
Diff-Quik stain and stain positively with calcitonin
A loose sheet of tumor cells showing minimal nuclear crowd- ing and two cells with intranuclear cytoplasmic inclusions in  FNA of a conventional papillary carcinoma (Diff-Quik stain, ×  400) Figure 11
A loose sheet of tumor cells showing minimal nuclear crowd-
ing and two cells with intranuclear cytoplasmic inclusions in 
FNA of a conventional papillary carcinoma (Diff-Quik stain, × 
400).
Two psammoma bodies in a smear showing a small amount  of colloid material Figure 12
Two psammoma bodies in a smear showing a small amount 
of colloid material. A small aggregate of poorly preserved fol-
licular cells is seen beside one psammoma body (Papanico-
laou stain, × 400).
A loose cluster of metaplastic squamous cells seen in FNA of  a conventional papillary carcinoma (Papanicolaou stain, ×  400) Figure 13
A loose cluster of metaplastic squamous cells seen in FNA of 
a conventional papillary carcinoma (Papanicolaou stain, × 
400).
Papillary carcinoma, microfollicular variant showing in FNA  cells in acinar arrangement Figure 14
Papillary carcinoma, microfollicular variant showing in FNA 
cells in acinar arrangement. A tumor cell with an intranuclear 
cytoplasmic inclusion is noted (Papanicolaou stain, × 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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antibody. Amyloid material that stains positively with
Congo red may be seen (Fig. 19).
4.d. A naplastic thyroid carcinoma consists of two main histo-
logic variants: Giant cell and spindle cell-subtypes. Depending
on the histologic subtype, an anaplastic thyroid carci-
noma may display in FNA pleomorphic large, bizarre can-
cer cells with prominent nucleoli or spindle cancer cells
admixed with a variable amount of necrotic debris (Figs.
20 and 21).
4.e. A primary thyroid non-Hodgkin lymphoma is usually of
large cell type and yields in FNA cells similar to those of a
lymph node involved by the same neoplastic process. A
thyroid Hodgkin disease is characterized by Reed-Sternberg
cells admixed with benign lymphoid cells and eosinophils
[13,24,25].
5. Cystic Lesion
Benign cysts account for the majority of thyroid cystic
lesions. They are formed as the result of hemorrhagic
Papillary carcinoma, tall-cell variant showing in FNA a sheet  of pleomorphic cells with some cells with elongated configu- ration and cytoplasmic tails Figure 15
Papillary carcinoma, tall-cell variant showing in FNA a sheet 
of pleomorphic cells with some cells with elongated configu-
ration and cytoplasmic tails. A tumor cell with intranuclear 
cytoplasmic inclusion is present (Diff-Quik stain, × 400).
Papillary carcinoma, diffuse sclerosing type showing in FNA a  sheet of metaplastic squamous cells, scattered lymphocytes  and a psammoma body (Papanicolaou stain, × 400) Figure 16
Papillary carcinoma, diffuse sclerosing type showing in FNA a 
sheet of metaplastic squamous cells, scattered lymphocytes 
and a psammoma body (Papanicolaou stain, × 400).
Medullary carcinoma showing in FNA dyshesive plasmacytoid  tumor cells with eccentrically located round nuclei and intra- cytoplasmic azurophil granules (Diff-Quik stain, × 400) Figure 17
Medullary carcinoma showing in FNA dyshesive plasmacytoid 
tumor cells with eccentrically located round nuclei and intra-
cytoplasmic azurophil granules (Diff-Quik stain, × 400).
Medullary carcinoma showing in FNA loosely clustered spin- dle-shaped tumor cells with scanty, ill-defined cytoplasm  (Papanicolaou stain, × 400) Figure 18
Medullary carcinoma showing in FNA loosely clustered spin-
dle-shaped tumor cells with scanty, ill-defined cytoplasm 
(Papanicolaou stain, × 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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degeneration of a benign colloid nodule. FNA from a
benign colloid cyst may show colloid material admixed
with benign follicular epithelial cells and hemosiderin
laden macrophages. However, any thyroid neoplasm may
undergo hemorrhagic necrosis and become a cystic lesion
[13,22-25]. Of the thyroid neoplasms, PC tends to
undergo marked hemorrhagic degenerative change. FNA
from the tumor commonly shows a large amount of
blood and the cystic lesion tends to recur rapidly [23].
Cytological examination of the aspiration smears usually
reveals a large amount of blood and rarely tumor cells.
However, sections from the cell block prepared from the
needle aspirate may show diagnostic papillary tissue
fragments with fibrovascular cores or nuclear features of a
PC [23] while that of a benign colloid nodule will show
no true papillary tissue fragments with fibrovascular cores
or nuclear features of a thyroid PC (Figs. 22 and 23).
A fragment of orange and granular amyloid material seen in  FNA of a thyroid medullary carcinoma (Papanicolaou stain, ×  400) Figure 19
A fragment of orange and granular amyloid material seen in 
FNA of a thyroid medullary carcinoma (Papanicolaou stain, × 
400).
Anaplastic carcinoma, giant-cell type showing in FNA single  and clustered large, bizarre malignant cells with pleomorphic  nuclei and prominent nucleoli (Papanicolaou stain, × 400) Figure 20
Anaplastic carcinoma, giant-cell type showing in FNA single 
and clustered large, bizarre malignant cells with pleomorphic 
nuclei and prominent nucleoli (Papanicolaou stain, × 400).
Anaplastic carcinoma, spindle-cell type showing in FNA dysh- esive spindle- shaped malignant cells with scant, ill-defined  cytoplasm (Papanicolaou stain, × 400) Figure 21
Anaplastic carcinoma, spindle-cell type showing in FNA dysh-
esive spindle- shaped malignant cells with scant, ill-defined 
cytoplasm (Papanicolaou stain, × 400).
Papillary tissue fragments with thin fibrovascular cores cov- ered with epithelial cells displaying nuclear crowding and  occasional intranuclear cytoplasmic inclusions seen in a cell  block section prepared from the needle aspirate of a papillary  carcinoma with hemorrhagic cystic degenerative change  (hematoxylin and eosin stain, × 250) Figure 22
Papillary tissue fragments with thin fibrovascular cores cov-
ered with epithelial cells displaying nuclear crowding and 
occasional intranuclear cytoplasmic inclusions seen in a cell 
block section prepared from the needle aspirate of a papillary 
carcinoma with hemorrhagic cystic degenerative change 
(hematoxylin and eosin stain, × 250).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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6. Thyroiditis
Hashimoto thyroiditis and  subacute thyroiditis commonly
have fairly distinctive clinical findings. Rarely, these
lesions may present as a nodular lesion mimicking a thy-
roid neoplasm. Hashimoto thyroiditis is characterized by
the presence of numerous benign lymphoid cells admixed
with benign follicular cells and Hurthle cells, (Figs. 24 and
25). A subacute thyroiditis may yield clustered epithelioid
cells, scattered lymphocytes and a few multinucleated
giant cells containing up to one hundred nuclei [13,22-
25,37] (Figs. 26 and 27). It should be born in mind that
Hashimoto thyroiditis may harbor hyperplastic follicular
and Hurthle cell nodules, and these two nodules are cyto-
logically indistinguishable from a cellular follicular
neoplasm and a Hurthle cell neoplasm, respectively
[37,38]. Surgical excision of these lesions is usually
required for histologic confirmation.
Section from a cell block prepared from the needle aspirate  of a benign colloid nodule with hemorrhagic cystic degenera- tive change showing papillary tissue fragments covered with  epithelium displaying no nuclear changes characteristic for a  papillary carcinoma (hematoxylin and eosin stain, × 250) Figure 23
Section from a cell block prepared from the needle aspirate 
of a benign colloid nodule with hemorrhagic cystic degenera-
tive change showing papillary tissue fragments covered with 
epithelium displaying no nuclear changes characteristic for a 
papillary carcinoma (hematoxylin and eosin stain, × 250).
Hashimoto thyroiditis showing in FNA numerous lymphoid  cells admixed with a sheet of follicular epithelial cells (Papani- colaou stain, × 100) Figure 24
Hashimoto thyroiditis showing in FNA numerous lymphoid 
cells admixed with a sheet of follicular epithelial cells (Papani-
colaou stain, × 100).
A sheet of follicular epithelial cells with oncocytic change  admixed with benign lymphoid cells seen in FNA of a Hashi- moto thyroiditis (Papanicolaou stain, × 400) Figure 25
A sheet of follicular epithelial cells with oncocytic change 
admixed with benign lymphoid cells seen in FNA of a Hashi-
moto thyroiditis (Papanicolaou stain, × 400).
A syncytial cluster of epithelioid cells with carrot-shaped  nuclei seen in FNA of a subacute thyroiditis (Diff-Quik stain,  × 400) Figure 26
A syncytial cluster of epithelioid cells with carrot-shaped 
nuclei seen in FNA of a subacute thyroiditis (Diff-Quik stain, 
× 400).CytoJournal 2005, 2:12 http://www.cytojournal.com/content/2/1/12
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7. Other Lesions
Graves disease may rarely present as a nodular thyroid
lesion [55]. It yields non specific cytologic findings [13].
Metastatic cancers to the thyroid are common in patients
with advanced cancers arising from other body sites [25].
However, metastatic cancer to the thyroid gland
presenting as a palpable TN is uncommon. For unknown
reasons, renal cell carcinoma is the most common
metastatic neoplasm to the thyroid, and cases of clinically
occult renal cell carcinoma presenting initially as a large
thyroid mass have been documented [25]. Cytodiagnosis
of metastatic cancer to the thyroid is relatively straightfor-
ward as metastatic cancer usually displays a cytologic pat-
tern distinctive from those of a primary thyroid carcinoma
[25]. However, a cytological differential diagnosis
between a metastatic renal cell carcinoma of clear cell type
and a primary thyroid carcinoma with clear cell change
may be difficult, and immunocytochemical staining of
aspirated tumor cells with thyroglobulin antibody will be
helpful to identify the aforementioned primary thyroid
cancer.
8. Non-Diagnostic Category
The lesions in this category are highly diversified and may
be any lesions listed in the above seven categories. In this
category the FNA yields non-diagnostic or inadequate
cellular materials. In one study, cystic thyroid lesions
yielded non-diagnostic cell samples at initial FNA in
about 50% of cases [12]. In the Mayo Clinic experience,
repeating the FNA in the cases with initial non-diagnostic
needle aspirates revealed diagnostic material in 30 to 80%
of cases [12,15]. Other investigators found that thyroid re-
FNA was of limited value [59]. If the re-aspiration is still
non-diagnostic, ultrasound-guided FNA should be per-
formed. Ultrasound-guided FNAs yield adequate cyto-
logic materials in about 91% of cases [27-36]. Patients
with no specific risk factors for thyroid malignancy and a
non-diagnostic FNA who refuse a re-biopsy may be man-
aged conservatively. While patients in the high-risk group
should have their TNs removed for histologic study, an
increase in nodule volume alone is not a reliable predictor
of malignancy, as most solid and benign TNs grow in size
[57].
Diagnostic Accuracy and Errors
In a review of seven large series totaling 18,183 thyroid
FNAs, Gharib and Goellner found that the biopsy
technique had a sensitivity rate varying from 65 to 98%
(mean 83%), and that its specificity rate varied from 72 to
100% (mean 92%) [15]. The false-negative rate varied
from 1 to 11.5% (mean, 5.2%), and the false-positive rate
varied from 0 to 7.7% (mean, 2.9%) [15]. The overall
cytodiagnostic accuracy rate of thyroid FNA approached
95% according to some reported series [13].
Adjunctive Diagnostic Value of Ancillary 
Techniques
Ultrafast Papanicolaou stain selectively swells the nuclei
of papillary thyroid carcinoma, making their nuclear
grooves disappear and making the swollen nuclei look
like "watery grapes", while this staining method has no
effect on nuclei of a follicular adenoma [21]. This artifac-
tual change is due to the disorganization of nuclear lam-
ins and permits a confident distinction between a
follicular adenoma and a follicular variant papillary carci-
noma [21]. Immunostaining with thyroid peroxidase
antibody has been reported to be of value in
distinguishing these two lesions, as malignant and benign
follicular cells commonly stain negatively and positively
with this antibody, respectively [58].
Ploidy determination has no value in distinguishing a fol-
licular adenoma from a follicular carcinoma [59-62] and
immunostaining for p53, Ki-67 and Bcl-2 has no value in
separating benign from malignant Hurthle cell tumors
[63].
Genetics-molecular studies have been extensively carried
out on tissue samples of different types of thyroid neo-
plasm since the past decade [64]. However, only a few
genetics-molecular studies on thyroid cells obtained by
FNA have been recently published. Human telomerase
reverse transcriptase (hTERT) gene expression, using
reverse transcriptase-polymerase chain reaction, has been
identified as a promising diagnostic marker in distin-
guishing benign from malignant tumors in materials
obtained by FNA. It was found that 90 and 92.8% of
thyroid carcinomas were positive for hTERT while 35 and
A large multinucleate giant cell present in FNA of a subacute  thyroiditis (Diff-Quik stain, × 400) Figure 27
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61.5% of benign thyroid nodules were positive for hTERT,
respectively [65,66]. Among the thyroid tumors with pos-
itive hTERT, there were eight of eight papillary, two of two
Hurthle cell and three of four follicular carcinomas [65].
BRAF point mutation and RET/thyroid PC rearrangements
were found in 38% of thyroid PCs and refined the
diagnosis of thyroid PC in five of fifteen cell samples that
were considered either indeterminate or insufficient by
cytology. No mutation was found in FNAs of follicular
adenomas and non-toxic nodular goiters [67]. These
molecular markers were of adjunctive diagnostic value
when the FNA diagnosis of TN was equivocal [65-67].
Powerful molecular techniques including microarray
analysis and molecular profiling may have a significant
role in the future evaluation of TNs, while providing
impetus for further insight into the molecular
pathogenesis of both benign and malignant TNs [68-71].
Moreover, such techniques may allow deeper insight into
both loss and gain of function of unidentified genes by
examining panels of genes rather than one or a limited
number of potential gene candidates. By analysis of can-
cer gene profiles for a cohort of 62 thyroid samples, Finley
et al [68] were able to distinguish between benign and
malignant thyroid tumors. They reported a sensitivity of
91.7% and specificity of 96.2% for the detection of thy-
roid carcinomas of various types, including thyroid PC
and its follicular variant and follicular carcinoma [68].
Distinction of benign and malignant thyroid tumors and
molecular classification of follicular thyroid tumors by
gene profiling suggests that these powerful techniques
may have significant diagnostic potential when used with
FNA cytology [69,70]. Molecular profiling may also
permit the distinction between primary and metastatic
malignancies when dealing with multiple suspicious nod-
ules at various sites. Using material retrieved by FNA,
Schoedel et al [71], compared loss of heterozygosity
(LOH) patterns and demonstrated genetic kinship of
multifocal carcinomas in the thyroid and a separate
nodule in the lung, supporting a diagnosis of metastatic
thyroid carcinoma to the lung rather than an independent
lung neoplasm.
At present, techniques such as microarray analysis are lim-
ited by the amount of RNA that can be retrieved from a
sample, thereby often limiting analysis to surgically
resected samples. However, refinement of these
techniques may make them applicable to FNA, with
extraction of RNA from a cell block from which molecular
analysis of FNA material may have significant diagnostic
benefit.
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